Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study.

Shilpa V, Bhagat R, Premalata CS, Pallavi VR, Ramesh G, Krishnamoorthy L.

Tumour Biol. 2014 May;35(5):4277-84. doi: 10.1007/s13277-013-1558-5. Epub 2014 Jan 3.

PMID:
24385383
[PubMed - indexed for MEDLINE]
2.

Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.

Wang C, Horiuchi A, Imai T, Ohira S, Itoh K, Nikaido T, Katsuyama Y, Konishi I.

J Pathol. 2004 Feb;202(2):215-23.

PMID:
14743504
[PubMed - indexed for MEDLINE]
3.

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P, Vergote I, Mahner S, Cacsire-Tong D, Concin N, Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI.

Eur J Cancer. 2014 Aug;50(12):2090-8. doi: 10.1016/j.ejca.2014.05.001. Epub 2014 Jun 2.

PMID:
24889916
[PubMed - indexed for MEDLINE]
4.

Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.

Bhagat R, Chadaga S, Premalata CS, Ramesh G, Ramesh C, Pallavi VR, Krishnamoorthy L.

Cell Oncol (Dordr). 2012 Dec;35(6):473-9. doi: 10.1007/s13402-012-0106-4. Epub 2012 Oct 10.

PMID:
23055343
[PubMed - indexed for MEDLINE]
5.

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.

Clin Cancer Res. 2005 Aug 1;11(15):5365-9.

PMID:
16061849
[PubMed - indexed for MEDLINE]
Free Article
6.

Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.

Vo LT, Thuan TB, Thu DM, Uyen NQ, Ha NT, To TV.

Asian Pac J Cancer Prev. 2013;14(12):7713-8.

PMID:
24460357
[PubMed - indexed for MEDLINE]
Free Article
7.

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY.

Cancer Res. 2000 Oct 1;60(19):5329-33.

PMID:
11034065
[PubMed - indexed for MEDLINE]
Free Article
8.

Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.

Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A.

Carcinogenesis. 2000 Feb;21(2):147-51.

PMID:
10657950
[PubMed - indexed for MEDLINE]
Free Article
9.

Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.

Yang G, Zhang H, Liu Y, Zhou J, He W, Quick CM, Xie D, Smoller BR, Fan CY.

Arch Gynecol Obstet. 2013 May;287(5):989-95. doi: 10.1007/s00404-012-2650-6. Epub 2012 Dec 4.

PMID:
23208459
[PubMed - indexed for MEDLINE]
10.

Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.

Wang YQ, Yan Q, Zhang JR, Li SD, Yang YX, Wan XP.

J Obstet Gynaecol Res. 2013 Feb;39(2):549-54. doi: 10.1111/j.1447-0756.2012.01979.x. Epub 2012 Sep 25.

PMID:
23006047
[PubMed - indexed for MEDLINE]
11.

Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin.

Dhillon VS, Young AR, Husain SA, Aslam M.

Br J Cancer. 2004 Feb 23;90(4):874-81.

PMID:
14970867
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.

Sernbo S, Gustavsson E, Brennan DJ, Gallagher WM, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck CA, Ek S.

BMC Cancer. 2011 Sep 24;11:405. doi: 10.1186/1471-2407-11-405.

PMID:
21943380
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

BRCA1 promoter hypermethylation in sporadic epithelial ovarian carcinoma: Association with low expression of BRCA1, improved survival and co-expression of DNA methyltransferases.

Bai X, Fu Y, Xue H, Guo K, Song Z, Yu Z, Jia T, Yan Y, Zhao L, Mi X, Wang E, Zheng Z, Zhao H, Yao W, Wei M.

Oncol Lett. 2014 Apr;7(4):1088-1096. Epub 2014 Feb 13.

PMID:
24944674
[PubMed]
Free PMC Article
14.

BRCA1 methylation: a significant role in tumour development?

Catteau A, Morris JR.

Semin Cancer Biol. 2002 Oct;12(5):359-371. Review. Erratum in: Semin Cancer Biol. 2003 Feb;13(1):91..

PMID:
12191635
[PubMed - indexed for MEDLINE]
15.

Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.

Bhagat R, Premalata CS, Shilpa V, Pallavi VR, Ramesh G, Vijay CR, Krishnamoorthy L.

Tumour Biol. 2013 Aug;34(4):2459-68. doi: 10.1007/s13277-013-0797-9. Epub 2013 Apr 19.

PMID:
23605324
[PubMed - indexed for MEDLINE]
16.

Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.

Catteau A, Harris WH, Xu CF, Solomon E.

Oncogene. 1999 Mar 18;18(11):1957-65.

PMID:
10208417
[PubMed - indexed for MEDLINE]
Free Article
17.

Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.

Wu Y, Zhang X, Lin L, Ma XP, Ma YC, Liu PS.

Asian Pac J Cancer Prev. 2014;15(3):1171-6.

PMID:
24606436
[PubMed - indexed for MEDLINE]
Free Article
18.

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.

PMID:
20470789
[PubMed - indexed for MEDLINE]
19.

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

Ignatov T, Eggemann H, Costa SD, Roessner A, Kalinski T, Ignatov A.

J Cancer Res Clin Oncol. 2014 Sep;140(9):1457-63. doi: 10.1007/s00432-014-1704-5. Epub 2014 May 14.

PMID:
24825122
[PubMed - indexed for MEDLINE]
20.

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG.

J Natl Cancer Inst. 2000 Apr 5;92(7):564-9.

PMID:
10749912
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk